Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer's disease.
Park YH, Pyun JM, Hodges A, Jang JW, Bice PJ, Kim S, Saykin AJ, Nho K, AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative. Alzheimers Res Ther. 2021 Nov 3; 13(1):183. Epub 2021 Nov 3.